SCIENTIFIC BACKGROUND

AIRE, ANOS1, BMP15, CAPN10, CHD7, CYP11A1, CYP17A1, CYP19A1, DENND1A, DUSP6, EIF2B2, EIF2B3, FEZF1, FGF8, FGF17, FGFR1, FIGLA, FLRT3, FMR1, FOXL2, FSHB, FSHR, GALT, GDF9, GNAS, GNRH1, GNRHR, HESX1, HS6ST1, IL17RD, INS, INSR, IRS1, IRS2, KISS1, KISS1R, LHB, LHCGR, NOBOX, NR5A1, NSMF, POF1B, POLG, PROK2, PROKR2, PSMC3IP, SEMA3A, SPRY4, STAG3, TAC3, TACR3, THADA, WDR11, WT1, ZP1

Category:

Scientific Background

Up to 10% of women have a genetic mutation (change in the DNA) which is linked with infertility.

Rodinia female panel screens for single nucleotide variants, insertions and deletions, as well as copy number variants in genes associated with female infertility. The panel also detects whole, partial and mosaic sex chromosome changes. Infertility genetic testing can guide treatment or clinical management options, enable early interventions to preserve fertility, and provide accurate prognostic assessment which can lead to a personalized clinical course of action.

 

Who is this test for?

• Individuals experiencing pregnancy delay

• Individuals with specific phenotype indicating a genetic syndrome associated with a sex chromosome aneuploidy

• Individuals with irregular or absent menstruation

• Individuals that will undergo assisted reproductive technology (ART) treatment

• Candidates for oocyte donation

• Individuals with family history of infertility 

 

Recommendations by professional bodies

Fragile X premutation carrier screening is recommended from the American College of Obstetricians and Gynecologists for women with a family history of fragile X-related disorders or intellectual disability suggestive of fragile X syndrome who are considering pregnancy or are currently pregnant. Women under 40 years old with unexplained ovarian insufficiency, or women with a family history of fragile X who are considering pregnancy or are currently pregnant are also recommended to have FMR1 premutation carrier screening. ACOG 2017

 

References

Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions. (2017). Obstetrics and gynecology, 129(3), 597–599. https://doi.org/10.1097/AOG.0000000000001948

NORD. (n.d.). Fragile X Syndrome. National Organization for Rare Disorders. Retrieved October 2021, from https://rarediseases.org/rare-diseases/fragile-x-syndrome/

Dukhovny S, Wilkins-Haug L. Genetic Basis of Female Infertility. In: Murray MF, Babyatsky MW, Giovanni MA, Alkuraya FS, Stewart DR. eds. Clinical Genomics: Practical Applications in Adult Patient Care, 1e. McGraw Hill; 2014. Accessed March 29, 2023. https://accessmedicine.mhmedical.com/content.aspx?bookid=1094&sectionid=61904709

Cariati F, D'Argenio V, Tomaiuolo R. The evolving role of genetic tests in reproductive medicine. J Transl Med. 2019;17(1):267. Published 2019 Aug 14. doi:10.1186/s12967-019-2019-8

 

How many genes are tested in this panel?

55 genes, plus X chromosome aneuploidies

 

What diseases are associated with the genes tested in this panel?

• Primary ovarian insufficiency

• Polycystic ovary syndrome

• Ovarian hyperstimulation syndrome

• Hypogonadotropic hypogonadism disorders, such as Kallmann syndrome

• Disorders of sexual development

GENES

AIRE, ANOS1, BMP15, CAPN10, CHD7, CYP11A1, CYP17A1, CYP19A1, DENND1A, DUSP6, EIF2B2, EIF2B3, FEZF1, FGF8, FGF17, FGFR1, FIGLA, FLRT3, FMR1, FOXL2, FSHB, FSHR, GALT, GDF9, GNAS, GNRH1, GNRHR, HESX1, HS6ST1, IL17RD, INS, INSR, IRS1, IRS2, KISS1, KISS1R, LHB, LHCGR, NOBOX, NR5A1, NSMF, POF1B, POLG, PROK2, PROKR2, PSMC3IP, SEMA3A, SPRY4, STAG3, TAC3, TACR3, THADA, WDR11, WT1, ZP1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more

Reproductive health is a fundamental aspect of human well-being, affecting individuals and communities worldwide [1]. It encompasses a wide range of ...

Read more

It seems as though everyone is talking about artificial intelligence, usually referred to as AI, these days! Indeed, not only are AI tools now access...

Read more

Orphan drugs are those developed specifically for the treatment of rare diseases. Within the pharmaceutical industry, the drug development process is...

Read more

A study of 629 pregnancies with ultrasound-detected anomalies found that exome sequencing identified pathogenic variants in 14% of cases. The detecti...

Read more

Breast cancer is a type of cancer that originates in the breast cells. Genetic changes in the DNA of the healthy breast cells can lead to the formati...

Read more